TREA

79285418 - SIMPROVA

Follow

Information

  • Trademark
  • 79285418
  • Serial Number
    79285418
  • Registration Number
    6375113
  • Filing Date
    October 29, 2019
    5 years ago
  • Registration Date
    June 08, 2021
    3 years ago
  • Transaction Date
    December 13, 2024
    14 days ago
  • Status Date
    June 08, 2021
    3 years ago
  • Published for Opposition Date
    March 23, 2021
    3 years ago
  • Location Date
    June 08, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    FAUCETTE,MAX C
  • Attorney Docket Number
    192870
    Attorney Name
    Holly M. Ford Lewis
    Law Office Assigned Location Code
    L70
  • Owners
Information
Mark Drawing Code
3
Mark Identification
SIMPROVA
Case File Statements
  • DM0000: The mark consists of the term "SIMPROVA" where the "S" is stylized like a DNA helix.
  • GS0091: Downloadable computer software used for medical examinations and diagnoses; computer hardware for data processing for scientific research or medical purposes; downloadable computer software for data processing for scientific research or medical purposes; computer programs, recorded, for the analysis of biological samples or microorganisms for scientific, research, or medical purposes; computer programs, downloadable, for the analysis of biological samples or microorganisms for scientific, research, or medical purposes; laboratory experimental machines and apparatus for the analysis of biological samples or microorganisms for scientific research purposes; laboratory apparatus and instruments for the analysis of biological samples or microorganisms for scientific research purposes; laboratory apparatus and instruments, namely, gene amplifiers; laboratory devices for detecting genetic sequences; molecular probes for scientific purposes other than for medical or veterinary purposes
  • GS0051: Diagnostic reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; pharmaceutical preparations for the analysis of biological samples; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing; nucleic acid-based reagents for medical or veterinary use; diagnostic preparations for medical or veterinary purposes, namely, nucleic acids, marking reagents, buffer chemicals, aqueous and non-aqueous solutions of primary, secondary and tertiary alcohols, salts, distilled water, purified water, and magnetic particles in fluid form; diagnostic preparations for medical or veterinary purposes, namely, materials for reaction vessels for purification, lysis, modification and manipulation of biological samples or microorganism, and for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds; diagnostic preparations for medical or veterinary purposes, namely, chemical, biochemical and biotechnological products, and kits comprising products for medical or veterinary purposes, namely, chemical, biochemical and biotechnological products for sample preparation, purification, lysis, modification and manipulation of biological samples or microorganism, and for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, namely, nucleic acids for medical and veterinary medical purposes, for detecting pathogens, genetic information and conditions of the human body
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0011: Chemical reagents for laboratory or research purposes, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; chemicals for use in industry and science; diagnostic reagents, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; chemical reagents for use in genetic research; nucleic acid-based reagents, other than for medical or veterinary purposes; chemical and biochemical preparations for industrial or scientific purposes, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes, namely, nucleic acids reagents, buffer solution, aqueous and non-aqueous solutions of alcohols, salts, distilled water, purified water, silica in powdered or granulated form, and magnetic particles in fluid form; chemical materials for reaction vessels for purification, lysis, modification and manipulation of biological samples or microorganism, and for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids for separation, analysis and purification of biological and biochemical compounds, none of the foregoing for medical or veterinary purposes; reagents and solvents for sample preparation for purification, lysis, modification and manipulation of biological samples or microorganism, and for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids for separation, analysis and purification of biological and biochemical compounds, none of the foregoing for medical or veterinary purposes; kits comprising chemical, biochemical and biotechnological products for preparation, purification, lysis, modification and manipulation of samples, and for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids, including nucleic acids made from biological and biochemical sample material, for separation, analysis and purification of biological and biochemical compounds, none of the foregoing for medical or veterinary purposes; reagent paper, other than for medical or veterinary purposes
  • GS0101: Diagnostic apparatus for medical purposes for the analysis of biological samples; fully automated nucleic acid-based reading and analysis medical instrument for rapid diagnostic of infections and diseases at point-of-care for personalized healthcare; genetic testing apparatus for medical or veterinary diagnostic use; clinical and medical diagnostic instruments, namely, nucleic acid analyzer; biological sample collection devices in the nature of medical devices for obtaining body fluid samples; medical specimen cups; disposable devices for analysis of biological samples for medical purposes; molecular probes for medical and veterinary medical purposes
Case File Event Statements
  • 5/22/2020 - 4 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/26/2020 - 4 years ago
    5 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 5/14/2020 - 4 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 5/21/2020 - 4 years ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 5/22/2020 - 4 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/29/2020 - 4 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 5/28/2020 - 4 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/8/2020 - 4 years ago
    11 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 9/8/2020 - 4 years ago
    12 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 9/8/2020 - 4 years ago
    13 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 9/8/2020 - 4 years ago
    16 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 9/8/2020 - 4 years ago
    14 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 9/8/2020 - 4 years ago
    15 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 6/29/2020 - 4 years ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 6/29/2020 - 4 years ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 7/18/2020 - 4 years ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 12/28/2020 - 4 years ago
    17 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/28/2020 - 4 years ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/29/2020 - 3 years ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/4/2021 - 3 years ago
    24 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 1/11/2021 - 3 years ago
    20 - FINAL REFUSAL WRITTEN Type: CNFR
  • 1/11/2021 - 3 years ago
    21 - FINAL REFUSAL E-MAILED Type: GNFR
  • 1/11/2021 - 3 years ago
    22 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 2/4/2021 - 3 years ago
    23 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 2/4/2021 - 3 years ago
    25 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 2/4/2021 - 3 years ago
    26 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/12/2021 - 3 years ago
    27 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/21/2021 - 3 years ago
    31 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 3/3/2021 - 3 years ago
    28 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/3/2021 - 3 years ago
    29 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 3/3/2021 - 3 years ago
    30 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 3/23/2021 - 3 years ago
    32 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/23/2021 - 3 years ago
    33 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/8/2021 - 3 years ago
    34 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/25/2021 - 3 years ago
    37 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 9/8/2021 - 3 years ago
    35 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 9/25/2021 - 3 years ago
    36 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 12/13/2024 - 14 days ago
    39 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 10/24/2021 - 3 years ago
    38 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO